Skip to main content
. 2021 Nov 10;12:6486. doi: 10.1038/s41467-021-26536-w

Fig. 5. Schematic illustration of crosstalk between liver follistatin production and adipocyte insulin-inhibited lipolysis.

Fig. 5

Liver follistatin (FST) secretion is regulated by GCKR-GCK, which is stimulated by glucagon and inhibited by insulin. Elevated follistatin may attenuate insulin-inhibited lipolysis in the adipocytes and mediate adipose tissue insulin resistance and free fatty acid (FFA) release, which ultimately contributes to T2D and NAFLD risk.